These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 11606371

  • 21. Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells.
    Tsai CM, Levitzki A, Wu LH, Chang KT, Cheng CC, Gazit A, Perng RP.
    Cancer Res; 1996 Mar 01; 56(5):1068-74. PubMed ID: 8640763
    [Abstract] [Full Text] [Related]

  • 22. Prevention of apoptosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the MCF-10A cell line: correlation with increased transforming growth factor alpha production.
    Davis JW, Lauer FT, Burdick AD, Hudson LG, Burchiel SW.
    Cancer Res; 2001 Apr 15; 61(8):3314-20. PubMed ID: 11309286
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: role of PI3 kinase and p38 MAP kinase pathways.
    Daly JM, Olayioye MA, Wong AM, Neve R, Lane HA, Maurer FG, Hynes NE.
    Oncogene; 1999 Jun 10; 18(23):3440-51. PubMed ID: 10376522
    [Abstract] [Full Text] [Related]

  • 25. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.
    Craft N, Shostak Y, Carey M, Sawyers CL.
    Nat Med; 1999 Mar 10; 5(3):280-5. PubMed ID: 10086382
    [Abstract] [Full Text] [Related]

  • 26. BIBX1382BS, but not AG1478 or PD153035, inhibits the ErbB kinases at different concentrations in intact cells.
    Egeblad M, Mortensen OH, van Kempen LC, Jäättelä M.
    Biochem Biophys Res Commun; 2001 Feb 16; 281(1):25-31. PubMed ID: 11178955
    [Abstract] [Full Text] [Related]

  • 27. Apoptosis induced by depsipeptide FK228 coincides with inhibition of survival signaling in lung cancer cells.
    Yu XD, Wang SY, Chen GA, Hou CM, Zhao M, Hong JA, Nguyen DM, Schrump DS.
    Cancer J; 2007 Feb 16; 13(2):105-13. PubMed ID: 17476138
    [Abstract] [Full Text] [Related]

  • 28. Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cells.
    Meng TC, Lee MS, Lin MF.
    Oncogene; 2000 May 18; 19(22):2664-77. PubMed ID: 10851066
    [Abstract] [Full Text] [Related]

  • 29. Protein kinase cepsilon has the potential to advance the recurrence of human prostate cancer.
    Wu D, Foreman TL, Gregory CW, McJilton MA, Wescott GG, Ford OH, Alvey RF, Mohler JL, Terrian DM.
    Cancer Res; 2002 Apr 15; 62(8):2423-9. PubMed ID: 11956106
    [Abstract] [Full Text] [Related]

  • 30. Activation of SAPK/JNK by camptothecin sensitizes androgen-independent prostate cancer cells to Fas-induced apoptosis.
    Costa-Pereira AP, McKenna SL, Cotter TG.
    Br J Cancer; 2000 Jun 15; 82(11):1827-34. PubMed ID: 10839298
    [Abstract] [Full Text] [Related]

  • 31. Therapeutic potential of curcumin in human prostate cancer. II. Curcumin inhibits tyrosine kinase activity of epidermal growth factor receptor and depletes the protein.
    Dorai T, Gehani N, Katz A.
    Mol Urol; 2000 Jun 15; 4(1):1-6. PubMed ID: 10851300
    [Abstract] [Full Text] [Related]

  • 32. Mechanisms of endocrine therapy-responsive and -unresponsive prostate tumours.
    Culig Z, Steiner H, Bartsch G, Hobisch A.
    Endocr Relat Cancer; 2005 Jun 15; 12(2):229-44. PubMed ID: 15947099
    [Abstract] [Full Text] [Related]

  • 33. Phenethyl isothiocyanate-induced apoptosis in p53-deficient PC-3 human prostate cancer cell line is mediated by extracellular signal-regulated kinases.
    Xiao D, Singh SV.
    Cancer Res; 2002 Jul 01; 62(13):3615-9. PubMed ID: 12097262
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effect of type I growth factor receptor tyrosine kinase inhibitors on phosphorylation and transactivation activity of the androgen receptor in prostate cancer cells: Ligand-independent activation of the N-terminal domain of the androgen receptor.
    Sugita S, Kawashima H, Tanaka T, Kurisu T, Sugimura K, Nakatani T.
    Oncol Rep; 2004 Jun 01; 11(6):1273-9. PubMed ID: 15138566
    [Abstract] [Full Text] [Related]

  • 36. Leptin signaling and apoptotic effects in human prostate cancer cell lines.
    Samuel-Mendelsohn S, Inbar M, Weiss-Messer E, Niv-Spector L, Gertler A, Barkey RJ.
    Prostate; 2011 Jun 15; 71(9):929-45. PubMed ID: 21541970
    [Abstract] [Full Text] [Related]

  • 37. Extracellular signal-regulated kinases are involved in the antiapoptotic effect of endothelin-1.
    Wu-Wong JR, Chiou WJ, Wang J.
    J Pharmacol Exp Ther; 2000 May 15; 293(2):514-21. PubMed ID: 10773023
    [Abstract] [Full Text] [Related]

  • 38. Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway.
    Tanaka Y, Gavrielides MV, Mitsuuchi Y, Fujii T, Kazanietz MG.
    J Biol Chem; 2003 Sep 05; 278(36):33753-62. PubMed ID: 12824193
    [Abstract] [Full Text] [Related]

  • 39. Cell cycle-independent death of prostate adenocarcinoma is induced by the trk tyrosine kinase inhibitor CEP-751 (KT6587).
    Dionne CA, Camoratto AM, Jani JP, Emerson E, Neff N, Vaught JL, Murakata C, Djakiew D, Lamb J, Bova S, George D, Isaacs JT.
    Clin Cancer Res; 1998 Aug 05; 4(8):1887-98. PubMed ID: 9717816
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of the Akt, cyclooxygenase-2, and matrix metalloproteinase-9 pathways in combination with androgen deprivation therapy: potential therapeutic approaches for prostate cancer.
    Miyamoto H, Altuwaijri S, Cai Y, Messing EM, Chang C.
    Mol Carcinog; 2005 Sep 05; 44(1):1-10. PubMed ID: 16044418
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.